Novel Erythropoiesis Stimulating Protein
A new glycosylated form of erythropoietin is currently in clinical testing
Duration of action is longer than recombinant human erythropoietin
Advantage: less frequent dosing
Notes:
New drugs with better effectiveness and higher cost will enter in the market.
41st American Society of Hematology Annual Meeting. Day 1 - December 4, 1999. A New Generation of Hematopoietic Growth Factors: A Glimpse Into the Future. John Wingard, MD -- Writer: Michelle L. Plante, PharmD